Key result
3,4-diaminopyridine induced an immediate bradycardia that was significantly greater in spontaneously hypertensive rats than in normotensive rats, demonstrating enhanced inhibitory control of KV channels.
Enhanced voltage-sensitive K+ channel activity in parasympathetic ganglia may explain the dysfunctional vagal heart rate control observed in hypertension.
Suggests KV channel hyperactivity contributes to vagal dysfunction in hypertension; leaves open human therapeutic relevance.
Parasympathetic withdrawal plays an important role in the autonomic dysfunctions in hypertension. Since hyperpolarizing, voltage-sensitive K(+) channels (K V) hamper transmitter release, elevated K V-activity may explain the disturbed vagal control of heart rate (HR) in hypertension. Here, the K V inhibitor 3,4-diaminopyridine was used to demonstrate the impact of K V on autonomic HR control. Cardiac output and HR were recorded by a flow probe on the ascending aorta in anesthetized, normotensive (WKY), and spontaneously hypertensive rats (SHR), and blood pressure by a femoral artery catheter. 3,4-diaminopyridine induced an initial bradycardia, which was greater in SHR than in WKY, followed by sustained tachycardia in both strains. The initial bradycardia was eliminated by acetylcholine synthesis inhibitor (hemicholinium-3) and nicotinic receptor antagonist/ganglion blocker (hexamethonium), and reversed to tachycardia by muscarinic receptor (mAchR) antagonist (atropine). The latter was abolished by sympatho-inhibition (reserpine). Reserpine also eliminated the late, 3,4-diaminopyridine-induced tachycardia in WKY, but induced a sustained atropine-sensitive bradycardia in SHR. Inhibition of the parasympathetic component with hemicholinium-3, hexamethonium, or atropine enhanced the late tachycardia in SHR, whereas hexamethonium reduced the tachycardia in WKY. In conclusion, 3,4-diaminopyridine-induced acetylcholine release, and thus enhanced parasympathetic ganglion transmission, with subsequent mAchR activation and bradycardia. 3,4-diaminopyridine also activated tachycardia, initially by enhancing sympathetic ganglion transmission, subsequently by activation of norepinephrine release from sympathetic nerve terminals. The 3,4-diaminopyridine-induced parasympathetic activation was stronger and more sustained in SHR, demonstrating an enhanced inhibitory control of K V on parasympathetic ganglion transmission. This enhanced K V activity may explain the dysfunctional vagal HR control in SHR.
No takes yet. Share an insight, caveat, or question.
Torill Berg (2015) studied Hypertension (n=166). 3,4-diaminopyridine vs. Normotensive WKY rats / Vehicle was evaluated on Immediate heart rate response (bradycardia) (p=0.005). 3,4-diaminopyridine induced an immediate bradycardia that was significantly greater in spontaneously hypertensive rats than in normotensive rats, demonstrating enhanced inhibitory control of KV channels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: